Clinical Trial Highlights

• Rosuvastatin in the Prevention of Stroke among Men and Women with Elevated Levels of C-Reactive Protein: The JUPITER Trial
• Whole Genome Association of Intracranial Aneurysm Identifies Susceptibilty Loci
• Final Results of the Clear IVH Trial: Clot Lysis, Safety and 180 Day Functional Outcomes
• Final Results of an FDA-approved Prospective, Multicenter, Single-Arm Trial of Stent-Assisted Recanalization for Acute Ischemic Stroke
• Results of a Randomized, Multi-Center Safety Trial of Perflutren Lipid Microspheres: TUCSON
• The Field Administration of Stroke Therapy—Magnesium (FAST-MAG) Phase III Clinical Trial
• Dramatic Early Improvement in the NINDS Trial: Better 90 Day Outcomes and No Increased Rates of Intracranial Hemorrhage
• How Safe is Intracranial Angioplasty and Stenting? Lessons Learned from 188 Interventions
• The Results of NEST-2: A Double-Blind, Randomized, Phase III Study Evaluating the Safety and Efficacy of Transcranial Laser Therapy for Acute Ischemic Stroke within 24 Hours of Stroke Onset
• Initial Post-Market Experience of the Penumbra System: Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke in the United States and Europe
• Eligibility for rt-PA within a Population: The Effect of the ECASS-3 Trial